Heartflow, Inc. (HTFL): Capital Expenditures
$5.03M
Year ended 2025-12-31
$6.95M
Trailing 12 months to 2026-06-30
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $5.03M | +15.3% | 2026-03-18, From 2025-01-01 |
| 2024-12-31 | $4.36M | -28.6% | 2026-03-18, From 2024-01-01 |
| 2023-12-31 | $6.11M | n/a | 2026-03-18, From 2023-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| Heartflow, Inc. (HTFL) | 2025-12-31 | $5.03M | +15.3% |
| SI-BONE, Inc. (SIBN) | 2025-12-31 | $8.41M | -19.8% |
| Neuronetics, Inc. (STIM) | 2025-12-31 | $801.0K | -45.4% |
| Treace Medical Concepts, Inc. (TMCI) | 2025-12-31 | $13.52M | +16.6% |
| InfuSystem Holdings, Inc (INFU) | 2025-12-31 | $560.0K | -48.7% |
| Xtant Medical Holdings, Inc. (XTNT) | 2025-12-31 | $2.38M | -42.1% |
| Cerus Corp (CERS) | 2025-12-31 | $3.73M | +31.4% |
| Orthopediatrics Corp (KIDS) | 2025-12-31 | $11.11M | -22.1% |
| Lemaitre Vascular Inc (LMAT) | 2025-12-31 | $6.78M | -2.6% |
Compare HTFL, SIBN, STIM, TMCI side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗